Forbes August 23, 2024
Angelica Mari

As industries increasingly turn to synthetic sources that mimic real components for product development, the Brazilian biotechnology firm Cellva is attracting investor interest with its approach to cultivated animal fat and bioingredients.

The São Paulo-based company has developed a process to grow pork fat in a lab environment without the need to slaughter animals, using advanced bioreactors to multiply fat cells extracted from a living pig. The lab-grown fat provides fatty acids like omega-3 and omega-9, while also offering an alternative to traditional animal fat in food products.

Beyond fat cultivation, Cellva also develops microcarriers and microcapsules. These platforms provide protection and controlled release of active ingredients and can be applied not only in the food industry but also in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article